®
White Paper: Congestive Heart Failure (CHF)
All rights reserved. IDEAL LIFE is a registered trademark in the United States for weight scales, blood glucose meters,
blood pressure cuffs and meters, heart monitors. IDEAL LIFE BODY MANAGER, IDEAL LIFE BP MANAGER, IDEAL
LIFE GLUCO MANAGER, IDEAL LIFE POD, REALIZING THE VISION OF A BETTER TOMORROW, Leveraging the
Power of Communication, Real time health and wellness information on demand, wireless remote health and wellness
management, and Solutions for better healthcare through advanced communication technology are all proprietary
trademarks of IDEAL LIFE INC. Contents are covered by one issued U.S. patent and one or more U.S. patents pending.
The information disclosed in this document is confidential and proprietary information of IDEAL LIFE INC. The information
is being provided on the assumption that it will be treated confidentially and for the sole purpose of informing clinical
professionals of suggested care practices present in public literature. The information should not be used as care practice
guidelines and health care professionals should use their own professional judgment when treating patients.
Property of: IDEAL LIFE INC.
Congestive Heart Failure (CHF)
Growing Problem - There are approximately
5.3 million people suffering from
congestive heart failure (CHF) in the United States. The lifetime risk of developing heart
failure at the age of 40 is 20%, and approximately 380,000 people above the age of 65
will be diagnosed with CHF annually. While the incidence of heart failure has remained
stable over the past 20 years, an increase in the over 65 year old demographic (attributed
to the aging baby boomer generation) coupled with longer survival rates will give rise to
a far greater number of heart failure patients in the coming years1.
Incidence of Hospitalization - A great cause for concern has been the increasing
number of patients being hospitalized with CHF. The number of patients with CHF
discharged from the hospital rose from 400,000 in 1979 to over 1 million in 20052.
Furthermore, within 4-6 months after discharge 47% of the patients are likely to be
readmitted3. In 2004, CHF was listed as the underlying cause in 57,120 deaths and it rose
to 284,365 when the total mention of diseases was included4. The five year mortality rate
for patients with CHF was 48% from 1996-20005.
Cost - The estimated total of direct and indirect cost of heart failure in the United States
for
2008 is
$34.8 billion with the greatest share being hospitalizations6. In the
commercially insured, Medicare and Medicaid populations, the single largest health
expenditure is inpatient utilization (nearly 33% in 2005) with 13.3% of all emergency
department visits associated with a hospital admission. The average cost associated with
a CHF hospitalization is $10,000. While approximately 14% of Medicare beneficiaries
have heart failure, they account for 43% of Medicare spending7.
1 American Heart Association. Heart Disease and Stroke Statistics — 2008 Update. Dallas, Texas:
American Heart Association; 2008. ©2008, American Heart Association
2 American Heart Association. Heart Disease and Stroke Statistics — 2008 Update. Dallas, Texas:
American Heart Association; 2008. ©2008, American Heart Association
3Sarwat I. Chaudhry, MD; Yongfei Wang, MS; John Concato, MD, MPH; Thomas M. Gill, MD; Harlan M.
Krumholz, MD, SM, Patterns of Weight Change Preceding Hospitalization for Heart Failure, Circulation.
2007;116:1549-1554
4 American Heart Association. Heart Disease and Stroke Statistics — 2008 Update. Dallas, Texas:
American Heart Association; 2008. ©2008, American Heart Association
5 Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J,
Yawn BP, Jacobsen SJ. Trends in heart failure incidence and survival in
a community-based population. JAMA. 2004;292:344 -350
6 American Heart Association. Heart Disease and Stroke Statistics — 2008 Update. Dallas, Texas:
American Heart Association; 2008. ©2008, American Heart Association
7 Ariel Linden, Dr.P.H., M.S. and Julia Adler-Milstein. Medicare Disease Management in Policy Context,
HealtH Care FinanCing review/Spring 2008/Volume 29, Number 3
2
Property of: IDEAL LIFE INC.
Current Population Based Interventions - Increases in body weight are associated
with hospitalization for heart failure and begin at least one week before admission. Daily
information about patients’ body weight identifies a high-risk period during which
interventions can be implemented to avert decompensated heart failure8. Current
intervention systems use scales and self-reporting via Integrated Voice Response (IVR)
and internet enabled scales. Interdictions come via telephonic notifications (calls by
nurses, etc).
The IDEAL LIFE Solution™ - The IDEAL LIFE CHF program has been successfully
tested and has been shown to decrease readmissions and optimize at-home treatment.
Through the use of a wireless internet enabled scale, combined with the remote IDEAL
LIFE information management platform™ a patient’s weight is immediately
communicated remotely to the CHF automatic data analysis engine. Within seconds of
stepping on a scale, information is logged and analyzed with alerts generated and
communicated in an appropriate manner.
IDEAL LIFE Results - A study was initiated on a population of 417 CHF patients in a
Medicare Special Needs Plan. The patients were divided into two populations. The first
required 217 patients to call a toll free number and enter their daily body weights through
the telephone over an Integrated Voice Response system (IVR). The second group of
200 patients used the IDEAL LIFE CHF program, which required patients to simply step
on an IDEAL LIFE scale that automatically sent weight readings to the IDEAL LIFE
information management platform™ (IL). Intervention calls were made by nurses when
reported weights fell outside medical guidelines (same for both study populations).
Client Retention - In the IVR group, 76 patients dropped out of the study (65%
retention), while only one patient dropped out of the IDEAL LIFE group (99.5%
retention). The IDEAL LIFE solution™ did not require any change in patient
routine daily behavior, a key factor that contributed to the high retention rate.
Reduction in Hospitalizations - In the three months prior to the initiation of the
study, the IVR group exhibited an admission rate of 620 per 1000 and the IL
group exhibited an admission rate of 630 per 1000; all related to CHF. Three
months after enrollment, the IL group displayed a
57% decline in hospital
admissions, or a 27% hospital admission rate; while the IVR group (65% of the
number intended to manage) had a 46% decline in hospital admissions, or a 33%
rate of hospital admissions.
When calculating the numbers of patients intended to manage (IM), it would be
expected that all those not retained on an intervention program would have
exhibited consistent patterns with usual care on an ongoing basis. The differences
for the IM patients groups are further striking: IM IVR patients showed a 31%
decline in admissions with a 43% rate of hospital admissions while the IM IL
8 Sarwat I. Chaudhry, MD; Yongfei Wang, MS; John Concato, MD, MPH; Thomas M. Gill, MD; Harlan
M. Krumholz, MD, SM, Patterns of Weight Change Preceding Hospitalization for Heart Failure,
Circulation. 2007;116:1549-1554
3
Property of: IDEAL LIFE INC.
patients still retained a 57% decline in admissions with a 27% rate of hospital
admissions.
Admissions Review
700
600
500
IVR
IDEAL LIFE
400
300
200
100
0
Before Enrollment
IM After Enrollment
Time
Patient Retention Rate
Care Method
Patients Enrolled
Patients Dropout
Retention rate
IDEAL LIFE
200
1
99.5%
IVR
217
76
65%
Hospital Admission Review
Care Method
Admissions per
Admissions per
Intended to Manage
Intended to
1000 prior to
1000 after
(IM) Admissions
Manage (IM)
enrollment
enrollment
per 1000
reduction of
Admissions
IDEAL LIFE
630
270
270
57%
IVR
620
330
430
31%
4
Property of: IDEAL LIFE INC.
Cost savings - In the chart below, cost savings for the three month program are
provided. On an annualized basis, prior to enrollment in the IDEAL LIFE CHF
program, the cost for total admissions (based on an average cost of $10,000 per
admission9) was $1,260,000 per 200 patients. After enrollment in the IDEAL
LIFE CHF program, the cost for total admissions was $540,000 per 200 patients.
During the program, existing staff resources were utilized and when using the
IDEAL LIFE Solution™ there was a realized cost savings of
$636,000.
Implementing the IDEAL LIFE Solution™ resulted in a return of $7.57 for every
dollar invested.
Return on Investment
Hospital
Cost for three
Cost Savings
Cost Savings
Return on
Care
Admissions
months
from
from Technology
Investment
Method
for three
(200 patients)
Technology
Implementation
months (200
Implementation
(%)
patients)
(200 patients)
Usual Care
31.5
$315,000
-
-
-
IDEAL
13.5
$135,000
$159,000
54%
$7.57 for
LIFE
every $1
invested
Costs and Savings
IDEAL LIFE cost
Admissions cost
Savings
9 Ariel Linden, Dr.P.H., M.S. and Julia Adler-Milstein. Medicare Disease Management in Policy Context,
HealtH Care FinanCing review/Spring 2008/Volume 29, Number 3
5